Comparison of bevacizumab and cabergoline in the treatment of ovarian hyperstimulation syndrome in a rat model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of bevacizumab and cabergoline in the treatment of ovarian hyperstimulation syndrome in a rat model

Published:2013-07-17 Issue:9 Volume:29 Page:851-854
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Engin-Ustun Yaprak,Yılmaz Saynur,Timur Hakan,Ustun Yusuf,Moraloglu Ozlem,Deveer Ruya,Yılmaz Nafiye

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2013.813470

Reference21 articles.

1. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment

2. Ovarian hyperstimulation syndrome: pathophysiology and prevention

3. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

4. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A

5. Cabergoline reduces the early onset of ovarian hyperstimulation syndrome: a prospective randomized study

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betaine Attenuates The Expression of Vasoactive Mediators and Histological Alterations Associated with Ovarian Hyperstimulation Syndrome in Rats;CELL J;2024

2. Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats;Revista da Associação Médica Brasileira;2023

3. Effect of ondansetron for preventing of ovarian hyperstimulation syndrome: in an experimental rat model;Gynecological Endocrinology;2022-12-02

4. Coenzyme Q10 improves ovarian histology and attenuates the expression of angiogenesis-associated proteins in the ovary of rats with experimental hyperstimulation syndrome;IRAN J BASIC MED SCI;2022

5. The Role of Angiogenic Factor Dysregulation in the Pathogenesis of Polycystic Ovarian Syndrome;Polycystic Ovary Syndrome;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3